Valuation: EUROAPI

Market Cap 117M 133M 109M 99.91M 188M 12.84B 191M 1.29B 505M 6.31B 500M 490M 21.82B P/E 2026 *
-1.54x
P/E 2027 * -2.91x
Enterprise Value 75.42M 85.87M 70.14M 64.36M 121M 8.27B 123M 833M 325M 4.07B 322M 315M 14.06B EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.14x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day-2.58%
3 months-2.58%
6 months-40.34%
Current year-42.59%
Current year 1.27
Extreme 1.27
2.54
1 year 1.27
Extreme 1.27
3.59
3 years 1.27
Extreme 1.27
12.7
5 years 1.27
Extreme 1.27
23.4
10 years 1.27
Extreme 1.27
23.4
Manager TitleAgeSince
Chief Executive Officer - 2024-12-08
Director of Finance/CFO - 2024-10-16
Compliance Officer - 2023-11-26
Director TitleAgeSince
Director/Board Member 62 2022-05-05
Director/Board Member - 2022-05-05
Chairman 57 2024-12-08
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%-.--% - - 133M
+0.86%+1.43%+47.17%+161.40% 1,067B
+1.59%+4.09%+56.51%+52.79% 635B
+0.95%+1.91%+36.30%+83.13% 458B
+1.60%+6.25%+37.00%+30.00% 347B
-0.60%+1.52%+36.67%+39.80% 295B
-0.14%+0.60%+17.29%+18.19% 262B
+0.09%-2.82%-29.09%-41.29% 216B
+1.22%+2.66%+22.66%+59.81% 203B
-1.18%-3.70%+11.28%+67.43% 161B
Average +0.18%+1.33%+26.20%+52.36% 404.83B
Weighted average by Cap. +0.76%+1.95%+35.99%+78.15%

Financials

2026 *2027 *
Net sales 760M 866M 707M 649M 1.22B 83.38B 1.24B 8.4B 3.28B 40.99B 3.25B 3.18B 142B 782M 890M 727M 667M 1.25B 85.7B 1.27B 8.63B 3.37B 42.13B 3.34B 3.27B 146B
Net income -75.7M -86.19M -70.4M -64.6M -121M -8.3B -123M -836M -327M -4.08B -324M -317M -14.11B -40.25M -45.83M -37.43M -34.35M -64.54M -4.41B -65.54M -445M -174M -2.17B -172M -168M -7.5B
Net Debt -41.66M -47.43M -38.74M -35.55M -66.8M -4.57B -67.83M -460M -180M -2.25B -178M -174M -7.76B -5.06M -5.76M -4.71M -4.32M -8.12M -555M -8.24M -55.92M -21.85M -273M -21.64M -21.18M -944M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.230EUR
Average target price
1.475EUR
Spread / Average Target
+19.92%

Quarterly revenue - Rate of surprise